Cargando…
Targeting the ubiquitin system by fragment-based drug discovery
The ubiquitin system contains a wealth of potential drug targets for many diseases and conditions, including neurodegenerative, immune, metabolic and developmental diseases, as well as multiple cancers. Despite years of research, relatively few clinical inhibitors or specific chemical probes for pro...
Autores principales: | Kennedy, Cassandra, McPhie, Katherine, Rittinger, Katrin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580268/ https://www.ncbi.nlm.nih.gov/pubmed/36275626 http://dx.doi.org/10.3389/fmolb.2022.1019636 |
Ejemplares similares
-
Application of Fragment-Based Drug Discovery to Versatile Targets
por: Li, Qingxin
Publicado: (2020) -
Using Structure-guided Fragment-Based Drug Discovery to Target Pseudomonas aeruginosa Infections in Cystic Fibrosis
por: Arif, Sheikh Mohammed, et al.
Publicado: (2022) -
Fragment-Based Drug Discovery by NMR. Where Are the Successes and Where can It Be Improved?
por: Mureddu, Luca G., et al.
Publicado: (2022) -
Structural basis for ubiquitylation by HOIL-1
por: Wu, Qilong, et al.
Publicado: (2023) -
Targeting Ubiquitin–Proteasome System With Copper Complexes for Cancer Therapy
por: Chen, Xin, et al.
Publicado: (2021)